Robert Rapaport

Robert Rapaport is a Research Analyst at RTW Investments, LP, based in New York, NY. In this role, he focuses on sourcing and evaluating investment opportunities within the medical technology sector, leveraging over two decades of expertise in healthcare investments. His primary responsibilities include conducting in-depth sector research and financial analysis on innovative medical technology companies, supporting the firm’s investment decisions in this specialized area.

Prior to joining RTW Investments, Mr. Rapaport served as Vice President and Senior Healthcare Analyst at Alger, where he contributed to the healthcare portfolio with a focus on specialty pharmaceuticals, biotechnology, and medical devices. He was also a Healthcare Analyst at Machaon Capital, where he covered various areas across the healthcare industry, further honing his expertise in fundamental equity research and sector analysis.

Mr. Rapaport holds a BS in Finance from the University of Maryland. Throughout his career, he has been recognized for his analytical acumen and deep sector knowledge, particularly in medical technology and healthcare equities, supporting investment strategies at leading asset management firms.